Jane Street’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$473K Sell
264,285
-229,564
-46% -$487K ﹤0.01% 8183
2025
Q4
$1.11M Buy
493,849
+424,856
+616% +$1.12M ﹤0.01% 5917
2025
Q3
$167K Sell
68,993
-522,695
-88% -$1.39M ﹤0.01% 9801
2025
Q2
$350K Buy
+591,688
New +$461K ﹤0.01% 7571
2024
Q4
Sell
-40,530
Closed -$77.8K 10307
2024
Q3
$77.8K Sell
40,530
-6,945
-15% -$15.8K ﹤0.01% 9074
2024
Q2
$117K Sell
47,475
-44,201
-48% -$119K ﹤0.01% 8669
2024
Q1
$150K Buy
91,676
+28,848
+46% +$42.4K ﹤0.01% 8344
2023
Q4
$112K Buy
62,828
+41,472
+194% +$88.9K ﹤0.01% 8534
2023
Q3
$97.8K Sell
21,356
-4,068
-16% -$38.9K ﹤0.01% 7963
2023
Q2
$284K Sell
25,424
-9,140
-26% -$97.3K ﹤0.01% 7211
2023
Q1
$391K Buy
+34,564
New +$368K ﹤0.01% 6751
2022
Q3
Sell
-150,007
Closed -$1.49M 10280
2022
Q2
$1.49M Sell
150,007
-458
-0.3% -$4.53K ﹤0.01% 4710
2022
Q1
$1.49M Buy
150,465
+263
+0.2% +$2.59K ﹤0.01% 5312
2021
Q4
$1.49M Buy
150,202
+202
+0.1% +$2K ﹤0.01% 5105
2021
Q3
$1.47M Hold
150,000
﹤0.01% 5116
2021
Q2
$1.52M Buy
+150,000
New +$1.52M ﹤0.01% 4908

Other funds holding PROK

Jane Street's PROK Position: Q1 2026 in Review

Jane Street reduced its ProKidney (PROK) stake by 46% in Q1 2026, selling an estimated $487K and leaving 264,285 shares worth $473K. The position accounts for ﹤0.01% of the portfolio, ranked #8183.

Jane Street first reported a position in PROK in Q2 2021 and has held it in 16 quarters since. The position peaked at $1.52M in Q2 2021. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Jane Street held 264,285 shares of ProKidney worth $473K as of Q1 2026.
  • Jane Street sold 229,564 ProKidney shares in Q1 2026, an estimated $487K.
  • ProKidney made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8183 holding.
  • Jane Street first reported a position in ProKidney in Q2 2021 and has held it in 16 quarters since.
  • Jane Street's ProKidney position peaked at $1.52M in Q2 2021.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.